Activated AKT and β‐catenin induced microscopic tumor foci by 4‐week in mice, in which synergistic activation of AKT and β‐catenin rapidly induced the progression from adenomas to HCC.134. This evidence concerns the gene AKT1 and hepatocellular carcinoma.